16
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Durable Remission after Splenectomy for Waldenström's Macroglobulinemia with Massive Splenomegaly in Leukemic Phase

, , , &
Pages 387-393 | Received 10 Aug 1996, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Stavroula Sofou, Richard Enmon, Stig Palm, Barry Kappel, Pat Zanzonico, Michael R. McDevitt, David A. Scheinberg & George Sgouros. (2010) Large anti-HER2/neu liposomes for potential targeted intraperitoneal therapy of micrometastatic cancer. Journal of Liposome Research 20:4, pages 330-340.
Read now
Morie A. Gertz. (2002) Waldenström's Macroglobulinemia: A Review of Therapy. Leukemia & Lymphoma 43:8, pages 1517-1526.
Read now
Yinlee Yoong, Paul J. Kurtin, Cristine Allmer, Susan Geyer, Thomas M. Habermann, David M. Nagorney & Thomas E. Witzig. (2001) Efficacy of Splenectomy for Patients with Mantle Cell Non-Hodgkin's Lymphoma. Leukemia & Lymphoma 42:6, pages 1235-1241.
Read now

Articles from other publishers (11)

Michael Oertel, Oliver Micke & Hans Theodor Eich. 2018. Radiation Oncology. Radiation Oncology 1 5 .
Noopur Raje, Teru Hideshima, Andrew J. Yee & Kenneth C. Anderson. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 32 .
Amey Bandekar, Charles Zhu, Rohit Jindal, Frank Bruchertseifer, Alfred Morgenstern & Stavroula Sofou. (2014) Anti–Prostate-Specific Membrane Antigen Liposomes Loaded with 225 Ac for Potential Targeted Antivascular α-Particle Therapy of Cancer . Journal of Nuclear Medicine 55:1, pages 107-114.
Crossref
Prashant Kapoor & James A. Martenson. 2014. Multiple Myeloma. Multiple Myeloma 233 244 .
Zhou Wei, Yu Yanxia, Xu Ying, Wang Han & Jiang Yuhua. (2012) Splenic re-irradiation for waldenstrőm’s macroglobulinemia. Radiation Oncology 7:1.
Crossref
Lijo Simpson & Morie Gertz. 2009. Myeloma Therapy. Myeloma Therapy 519 550 .
Prashant Kapoor, Ekta Singh, Priya Radhakrishnan & Paulette Mehta. (2006) Splenectomy in plasma cell dyscrasias: A review of the clinical practice. American Journal of Hematology 81:12, pages 946-954.
Crossref
C.I. Chen. (2004) Treatment for Waldenstrom’s macroglobulinemia. Annals of Oncology 15:4, pages 550-558.
Crossref
Morie A. Gertz, Athanasios Anagnostopoulos, Kenneth Anderson, Andrew R. Branagan, Morton Coleman, Stanley R. Frankel, Sergio Giralt, Todd Levine, Nikhil Munshi, Alan Pestronk, Vincent Rajkumar & Steven P. Treon. (2003) Treatment recommendations in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Seminars in Oncology 30:2, pages 121-126.
Crossref
Véronique Leblond, Vincent Lévy, Frédéric Maloisel, Bruno Cazin, Jean-Paul Fermand, Jean-Luc Harousseau, Liliane Remenieras, Raphaël Porcher, Martine Gardembas, Gérald Marit, Eric Deconinck, Bernard Desablens, François Guilhot, Guilaine Philippe, Aspasia Stamatoullas & Odile Guibon. (2001) Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease. Blood 98:9, pages 2640-2644.
Crossref
Meletios A. DimopoulosPanayiotis PanayiotidisLia A. MoulopoulosPetros SfikakisMarinos Dalakas. (2000) Waldenström’s Macroglobulinemia: Clinical Features, Complications, and Management. Journal of Clinical Oncology 18:1, pages 214-214.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.